|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/496 |
| (11) | Number of the document | 1912625 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06776678.2 |
| Date of filing the European patent application | 2006-08-08 | |
| (97) | Date of publication of the European application | 2008-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2006/007839 |
| Date | 2006-08-08 |
| (87) | Number | WO 2007/017248 |
| Date | 2007-02-15 |
| (30) | Number | Date | Country code |
| 595816 P | 2005-08-08 | US |
| (72) |
BERNDL, Gunther, DE
DEGENHARDT, Matthias, DE
MÄGERLEIN, Markus, DE
DISPERSYN, Gerrit, US
|
| (73) |
AbbVie Deutschland GmbH & Co KG,
Max-Planck-Ring 2a, 65205 Wiesbaden,
DE
Barrier Therapeutics, Inc., 600 College Road East, Suite 3200, Princeton, NJ 08540, US |
| (54) | ITRACONAZOLE COMPOSITIONS WITH IMPROVED BIOAVAILABILITY |
| ITRACONAZOLE COMPOSITIONS WITH IMPROVED BIOAVAILABILITY |